Just hours after the confirmation of Robert F Kennedy Jr as Health and Human Services Secretary, President Trump issued an ...

The agreement with Roche will “substantially” increase the number of doses available if the drug works in clinical trials. REGN-COV2 was the ... in people exposed to SARS-CoV-2, with initial ...

In addition to these proven drugs, the year saw the development of many new compounds ... significantly quicker resolution of the five typical symptoms of the Omicron SARS-CoV2 (Yamato et al., 2024).

Given the drug pipeline and lessons learnt regarding trial design ... the efficacy and safety of vaccination against herpes zoster and SARS-CoV2 viruses (a general SLR for infection prevention was not ...

Video Back Videos home Signature collection Essentials collection Artificial Intelligence ...

The antiviral combination of nirmatrelvir and ritonavir (brand name Paxlovid) is an effective treatment for people with COVID-19 who have mild symptoms and face a high risk of hospitalization. For ...

Hologic (HOLX) announced that the FDA has granted 510(k) clearance for the company’s Aptima SARS-CoV-2 assay, which was first granted Emergency ...

Findings indicate a sharp drop in immunity after Omicron infection, stressing the necessity for updated vaccines to enhance ...

of the SARS-CoV-2 spike glycoprotein, derived from the Brazilian genome sequence, and seven clinically approved drugs: umifenovir, darunavir, lopinavir, ritonavir, remdesivir, pirfenidone ...